Paper1100221
Clinical comparison of the nitrosoureas.
Wasserman TH and 2 others. Cancer, 1975. Cited by 131 papers, by iCite.
Cite this record
ConductScience Library. Clinical comparison of the nitrosoureas. Papers, record 1100221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1100221
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Nitrosourea Compounds | Major topic |
| Animals | |
| Brain Neoplasms | |
| Breast Neoplasms | |
| Carmustine | |
| Chemical Phenomena | |
| Chemistry | |
| Colonic Neoplasms | |
| Drug Therapy, Combination | |
| Hodgkin Disease | |
| Humans | |
| Lomustine | |
| Lung Neoplasms | |
| Lymphoma | |
| Melanoma | |
| Methylnitrosourea | |
| Mice | |
| Neoplasms, Experimental | |
| Rectal Neoplasms |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18155673 | Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth. | Free Radic Biol Med | 2008 | https://conductscience.org/library/papers/18155673 | PubMed |
| 8699236 | Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas. | J Neurooncol | 1996 | https://conductscience.org/library/papers/8699236 | PubMed |
| 7002528 | Cancer chemotherapy: new developments and changing concepts. | Drugs | 1980 | https://conductscience.org/library/papers/7002528 | PubMed |
| 6678867 | The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678867 | PubMed |
| 6585127 | Treatment of malignant brain tumours with ACNU and phenobarbital: continuous infusion of ACNU into internal carotid artery and systemic administration of phenobarbital. | Acta Neurochir (Wien) | 1984 | https://conductscience.org/library/papers/6585127 | PubMed |
| 6379509 | Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas. | Neurosurg Rev | 1984 | https://conductscience.org/library/papers/6379509 | PubMed |
| 6357517 | CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6357517 | PubMed |
| 6249513 | Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6249513 | PubMed |
| 6182702 | Palliative and adjunctive measures in rectal cancer. | World J Surg | 1982 | https://conductscience.org/library/papers/6182702 | PubMed |
| 4066223 | Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study. | Invest New Drugs | 1985 | https://conductscience.org/library/papers/4066223 | PubMed |
| 2931097 | DNA repeat length in chromatin from murine bone marrow and L1210 leukaemia cells. | Br J Cancer | 1985 | https://conductscience.org/library/papers/2931097 | PubMed |
| 2225319 | Renal effects of S10036 in man. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2225319 | PubMed |
| 1742855 | Positive phase II study in the treatment of advanced malignant melanoma with fotemustine. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/1742855 | PubMed |
| 1428724 | Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse model. | Invest New Drugs | 1992 | https://conductscience.org/library/papers/1428724 | PubMed |
| 1331343 | Treatment of malignant gliomas with surgery, intraarterial chemotherapy with ACNU and radiation therapy. | J Neurooncol | 1992 | https://conductscience.org/library/papers/1331343 | PubMed |
| 468900 | Antitumor activity of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea (MeCCNU) on Yoshida sarcoma ascites cells implanted into the colon wall of rats. | J Cancer Res Clin Oncol | 1979 | https://conductscience.org/library/papers/468900 | PubMed |
| 92860 | An A,B,C,D of cancer chemotherapy. | West J Med | 1979 | https://conductscience.org/library/papers/92860 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1100221
GET https://conductscience.org/api/papers/v1/1100221/authors